Details of the Metabolic Reaction (MR) | INTEDE

General Information of This Metabolic Reaction (MR) (ID: MR009064)
Formula	SULT2A1 Unclear
	Reactant	Bevacizumab + Trastuzumab		Product	Tauro-LCA (TLCA)
	Reactant	Reactant Info		Product	Product Info
Metabolic Enzyme	Sulfotransferase 2A1 (SULT2A1)					DME Info
Metabolic Type	Unclear - Unclear

Other MR(s) Related to The Reactant of This MR

Other MR(s) That Metabolize The Reactant of This MR

MR ID	Reactant	Product	MR Type	Related Drug	REF
MR009057	Bevacizumab + Trastuzumab	3-Keto-lithocholic acid(3KLA)	Unclear - Unclear	Bevacizumab + Trastuzumab	[1]
MR009063	Bevacizumab + Trastuzumab	Glyco-LCA (GLCA)	Unclear - Unclear	Bevacizumab + Trastuzumab	[2]

References
1	The metabolism of lithocholic acid and lithocholic acid-3-alpha-sulfate by human fecal bacteria
2	Inhibition of Human Sulfotransferase 2A1-Catalyzed Sulfonation of Lithocholic Acid, Glycolithocholic Acid, and Taurolithocholic Acid by Selective Estrogen Receptor Modulators and Various Analogs and Metabolites

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.